Reversing inflammation in children with sepsis-induced organ dysfunction
Official title: Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS (TRIPS)
Run by Nationwide Children's Hospital · NCT05267821 · Data updated 2026-11-12
This study is testing if a drug called anakinra can help children with sepsis-induced organ problems by reducing inflammation.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Ages | 1 Day to 17 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Nationwide Children's Hospital Academic / other |
| Locations | 32 sites (Birmingham, Alabama and 31 other locations) |
| Status | Recruiting |
| Started | June 14, 2022 |
| Main results expected | May 15, 2028 |
| Study ends | August 31, 2028 |
| Registry record updated | March 13, 2026 |
| Trial ID | NCT05267821 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 40 weeks to under 18 years with recent onset of multiple organ dysfunction due to sepsis.
✕Probably not a fit
Patients with severe underlying conditions or those unlikely to survive the next 48 hours may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The TRIPS study is a multi-center, double-blind, randomized clinical trial investigating the use of anakinra, a drug aimed at reversing hyperinflammation in children suffering from sepsis-induced multiple organ dysfunction syndrome (MODS). Eligible participants will be children aged from 40 weeks corrected gestational age to under 18 years who have developed two or more new organ dysfunctions within three days of sepsis onset. The trial will involve administering intravenous anakinra or a placebo for seven days, with careful monitoring of immunological responses. Centralized immunophenotyping will be conducted to assess eligibility based on specific inflammatory markers.
Why it matters
Potential benefit: If successful, this treatment could significantly improve recovery outcomes for children suffering from severe sepsis-induced organ dysfunction.
How similar studies have gone: Other studies have explored similar approaches to treating sepsis-induced inflammation, but the specific use of anakinra in this context is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥ 40 weeks corrected gestational age to \< 18 years; AND * Admission to the PICU or CICU; AND * Onset of ≥ 2 new organ dysfunctions within the last 3 calendar days (compared to pre-sepsis baseline) as measured by the modified Proulx criteria; AND * Documented or suspected infection as the MODS inciting event. Exclusion Criteria: * Weight \<3kg; OR * Limitation of care order at the time of screening; OR * Patients at high likelihood of progression to brain death in opinion of the clinical team; OR * Moribund condition in which the patient is unlikely to survive the next 48 hours in opinion of the clinical team; OR * Current or prior diagnosis of hemophagocytic lymphohistiocytosis or macrophage activation syndrome; OR * Peripheral white blood cell count \< 1,000 cells/mm3 as the result of myeloablative therapy OR receipt of myeloablative therapy within the previous 14 days; OR * Known allergy to anakinra, or E. coli-derived products; OR * Known pregnancy; OR * Lactating females; OR * Receipt of anakinra within the previous 28 days; OR * Resolution of MODS by MODS Day 2; OR * Previous enrollment in the TRIPS study.
Where it's running
-
Children's of Alabama
Birmingham, Alabama, United States Recruiting -
Arkansas Children's Hospital
Little Rock, Arkansas, United States Recruiting -
Children's Hospital of Los Angeles
Los Angeles, California, United States Recruiting -
Benioff Children's Hospital - Oakland
Oakland, California, United States Recruiting -
University of California, Davis
Sacramento, California, United States Recruiting -
Rady Children's Hospital
San Diego, California, United States Recruiting
Show 26 more locations
-
Benioff Children's Hospital - Mission Bay
San Francisco, California, United States Recruiting -
Children's Hospital Colorado
Aurora, Colorado, United States Recruiting -
Children's National Medical Center
Washington D.C., District of Columbia, United States Recruiting -
Children's Hospital of Atlanta
Atlanta, Georgia, United States Recruiting -
Riley Children's Hospital
Indianapolis, Indiana, United States Recruiting -
CS Mott Children's Hospital
Ann Arbor, Michigan, United States Recruiting -
Children's Hospital of Michigan
Detroit, Michigan, United States Recruiting -
University of Minnesota
Minneapolis, Minnesota, United States Recruiting -
Mercy Children's Hospital
Kansas City, Missouri, United States Recruiting -
Duke University
Durham, North Carolina, United States Recruiting -
Akron Children's Hospital
Akron, Ohio, United States Recruiting -
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States Recruiting -
Rainbow Babies and Children's Hospital
Cleveland, Ohio, United States Recruiting -
Nationwide Children's Hospital
Columbus, Ohio, United States Recruiting -
Pennsylvania State University
Hershey, Pennsylvania, United States Recruiting -
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States Recruiting -
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States Recruiting -
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting -
University of Texas Southwestern
Dallas, Texas, United States Recruiting -
Texas Children's Hospital
Houston, Texas, United States Recruiting -
Children's Hospital of San Antonio
San Antonio, Texas, United States Recruiting -
Primary Children's Hospital
Salt Lake City, Utah, United States Recruiting -
Virginia Commonwealth University
Richmond, Virginia, United States Recruiting -
Children's Hospital of Orange County
Orange, California, United States Not yet recruiting -
Children's Hospital of Minnesota
Minneapolis, Minnesota, United States Not yet recruiting -
Medical College of Wisconsin
Milwaukee, Wisconsin, United States Not yet recruiting
Study contacts
- Study coordinator: Mark Hall, MD
- Email: mark.hall@nationwidechildrens.org
- Phone: 6147223438
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transauricular Neurostimulation for Abdominal Pain in Teens
We are testing a head- and ear‑based device to see if it helps teens with abdominal pain from gut-brain disorders.
-
MedMemos: helping families stick to medications after pediatric stem cell transplant
MedMemos tests a caregiver-focused program to help families of children who had a bone marrow transplant take medications more consistently.
-
Light therapy for children in the pediatric ICU
This project will try daily bedside light therapy for children aged 4–17 in the pediatric ICU to see how easy it is to deliver and whether patients, families, and staff tolerate it.
-
Food is Medicine program to boost family heart health
The trial tests whether providing healthy food access plus personalized digital tools and coaching can improve heart health for families with a parent on Medicaid and a 6–11 year old child.
-
AI-based personalized health and self-care support for caregivers of children
This pilot will test whether the DAPHNE chatbot helps caregivers of children with unmet social needs connect to community resources, stay engaged, and fit into primary care workflows over six months.
-
Caregiver questionnaire on firearm ownership and safety
We will ask parents and legal guardians of children having surgery at Nationwide Children's Hospital about firearm ownership, storage, access, and safety education to see if common safety practices are followed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.